Inhaled triple therapy in individuals with Chronic Obstructive Pulmonary Disease and indications of pulmonary rehabilitation
M Vitacca, M Paneroni, A Spanevello… - European Journal of …, 2022 - ejinme.com
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease,
characterized by persistent and progressive airflow limitation, worsening reduced exercise
capacity, and health-related quality of life (HRQL). Global Initiative for Chronic Obstructive
Lung Disease (GOLD) guidelines recommend inhaled combined therapy with a long-acting
muscarinic antagonist (LAMA), long-acting beta2-agonist (LABA), and inhaled
corticosteroids (ICS)(triple therapy: TT) in fixeddose (single-inhaler therapy) or free-dose …
characterized by persistent and progressive airflow limitation, worsening reduced exercise
capacity, and health-related quality of life (HRQL). Global Initiative for Chronic Obstructive
Lung Disease (GOLD) guidelines recommend inhaled combined therapy with a long-acting
muscarinic antagonist (LAMA), long-acting beta2-agonist (LABA), and inhaled
corticosteroids (ICS)(triple therapy: TT) in fixeddose (single-inhaler therapy) or free-dose …
以上显示的是最相近的搜索结果。 查看全部搜索结果